Articles

August 3, 2018 Barry Greene Named to PharmaVoice 100 "For Being an RNAi Champion" Alnylam President Barry Greene has been named to the PharmaVoice 100 for 2018.  Barry was selected "for being an RNAi champion." Read More ›
June 19, 2018 Guest Post: Finding Hope in a Potential New Class of Medicines Amyloidosis first entered my husband’s life and my life in the mid-1990s, when we began to care for my uncle who had amyloidosis, a time I call the “dark ages. Read More ›
June 19, 2018 Guest Post: The Heroes Among Us For many of us, it’s unimaginable to think of a daily life filled with intractable pain. It’s also hard to imagine caring for someone in pain of that... Read More ›
April 30, 2018 Hunting for Targets: Bringing RNAi to Humans Evolution is a powerful force, and Mother Nature is often a great source of inspiration for drug hunters like me. If you look at the history of successful... Read More ›
April 30, 2018 Building to Scale: Raising RNAi Therapeutics From Infancy When I joined Alnylam in 2004, one of our early challenges was figuring out how to manufacture and deliver RNAi therapeutics for our clinical trials. The... Read More ›
February 28, 2018 Harnessing the Power of RNAi™: Pushing Through the Challenges and Setbacks I am an organic chemist, and what keeps me going after 3 decades working in the field of oligonucleotides is transforming complex chemistry into medicines... Read More ›
February 28, 2018 A Note from Nicole Boice of Global Genes: Hope Is on the Horizon On this Rare Disease Day—and as is the case each year on February 28—I’m reminded of why I founded Global Genes nearly a decade ago. At that time, I was just... Read More ›
February 28, 2018 RNAi Therapeutics: From Eureka! Moment to a Potential New Class of Medicines How far science and technology have come! At Alnylam, we believe we’re on the verge of a landmark moment in medicine and I can’t help but express my... Read More ›
January 18, 2018 Alnylam Co-Founds UK Biobank Exome Sequencing Consortium (UKB-ESC) Alnylam and partners announced an agreement with the UK Biobank to form the UK Biobank Exome Sequencing Consortium (UKB-ESC), to sequence all 500,000 exomes... Read More ›
Subscribe to Articles